Recent studies have shown that osteopontin, a cytokine with suggested immunoregulatory functions, may contribute to pathogenesis of asthma. To determine whether single-nucleotide polymorphisms (SNPs) in SPP1, the gene encoding osteopontin, are associated with risk of asthma, we genotyped 6 known SNPs in SPP1 in the well-characterized Genetics of Asthma in Latino Americans population of 294 Mexican and 365 Puerto Rican parent–child asthma trios. The associations between SNPs and asthma or asthma-related phenotypes were examined by transmission disequilibrium tests as implemented in the family-based association test program. Three polymorphisms, 1 in exon 7 (rs1126616C) and 2 in the 3′-untranslated region (rs1126772A and rs9138A) of SPP1, were associated with diagnosis of asthma, severity of asthma, asthma in subjects with elevated immunoglobulin E (IgE) (IgE >100 IU/mL), and postbronchodilator FEV1 in Puerto Ricans (P values=0.00007–0.04). The CC genotype of rs1126616 conferred an odds ratio of 1.7 (95% CI=[1.3, 2.3], P value adjusted for multiple comparisons=0.001) for asthma compared with the CT and TT genotypes. Furthermore, haplotype analysis identified rs1126616C-rs1126772A-rs9138A to be associated with an increased risk for asthma, severity of asthma, and asthma in subjects with elevated IgE (P=0.03). There was no association between the SPP1 SNPs and asthma outcomes in Mexicans. Our findings suggest that the SPP1 gene is a risk factor for asthma and asthma-related phenotypes in Puerto Ricans, and are consistent with previous animal and human studies on the role of osteopontin in pathogenesis of asthma.
Get full access to this article
View all access options for this article.
References
1.
AshkarS, WeberGF, PanoutsakopoulouVet al.Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 2000; 287:860–864.
2.
ChabasD, BaranziniSE, MitchellDet al.The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science, 2001; 294:1731–1735.
TruebloodNA, XieZ, CommunalCet al.Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res, 2001; 88:1080–1087.
5.
O'ReganA. The role of osteopontin in lung disease. Cytokine Growth Factor Rev, 2003; 14:479–488.
6.
QinC, BabaO, ButlerWT. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med, 2004; 15:126–136.
RittlingSR, DenhardtDT. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol, 1999; 7:103–113.
9.
RolloEE, LaskinDL, DenhardtDT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukoc Biol, 1996; 60:397–404.
10.
MiyazakiY, SetoguchiM, YoshidaS, HiguchiY, AkizukiS, YamamotoS. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem, 1990; 265:14432–14438.
11.
RolloEE, DenhardtDT. Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology, 1996; 88:642–647.
12.
PatarcaR, SaavedraRA, CantorH. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol, 1993; 13:225–246.
13.
WeberGF, CantorH. The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev, 1996; 7:241–248.
14.
GiachelliCM, BaeN, AlmeidaM, DenhardtDT, AlpersCE, SchwartzSM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest, 1993; 92:1686–1696.
15.
XanthouG, AlissafiT, SemitekolouMet al.Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med, 2007; 13:570–578.
16.
SimoesDC, XanthouG, PetrochilouK, PanoutsakopoulouV, RoussosC, GratziouC. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med, 2009; 179:894–902.
17.
KohanM, BaderR, PuxedduI, Levi-SchafferF, BreuerR, BerkmanN. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy, 2007; 37:1444–1454.
18.
KohanM, BreuerR, BerkmanN. Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol, 2009; 41:290–296.
19.
ArjomandiM, RenX, HuangK, HuangX. Osteopontin knockout mice show diminished airway hyperreactivity despite increased eosinophilic inflammation and IgE production in an experimental model of allergic asthma. Am J Respir Crit Care Med, 2009; 175:A1393.
20.
PuxedduI, BerkmanN, RibattiDet al.Osteopontin is expressed and functional in human eosinophils. Allergy, 2010; 65:168–174.
21.
TakahashiA, KurokawaM, KonnoSet al.Osteopontin is involved in migration of eosinophils in asthma. Clin Exp Allergy, 2009; 39:1152–1159.
22.
SamitasK, ZervasE, VittorakisSet al.Osteopontin expression and relation to disease severity in human asthma. Eur Respir J, 2011; 37:331–341.
23.
TaninoY, HizawaN, KonnoSet al.Sequence variants of the secreted phosphoprotein 1 gene are associated with total serum immunoglobulin E levels in a Japanese population. Clin Exp Allergy, 2006; 36:219–225.
24.
BurchardEG, AvilaPC, NazarioSet al.Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med, 2004; 169:386–392.
25.
HankinsonJL, OdencrantzJR, FedanKB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med, 1999; 159:179–187.
26.
WuthrichB, SchindlerC, MediciTC, ZellwegerJP, LeuenbergerP. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team. Int Arch Allergy Immunol, 1996; 111:396–402.
27.
CourtCS, CookDG, StrachanDP. Comparative epidemiology of atopic and non-atopic wheeze and diagnosed asthma in a national sample of English adults. Thorax, 2002; 57:951–957.
28.
HaagerupA, BjerkeT, SchoitzPO, BinderupHG, DahlR, KruseTA. Allergic rhinitis—a total genome-scan for susceptibility genes suggests a locus on chromosome 4q24-q27. Eur J Hum Genet, 2001; 9:945–952.
29.
AschardH, BouzigonE, CordaEet al.Sex-specific effect of IL9 polymorphisms on lung function and polysensitization. Genes Immun, 2009; 10:559–565.
30.
CantorH, ShinoharaML. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat Rev Immunol, 2009; 9:137–141.
31.
ShinoharaML, JanssonM, HwangES, WerneckMB, GlimcherLH, CantorH. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A, 2005; 102:17101–17106.
32.
WangKX, DenhardtDT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev, 2008; 19:333–345.
33.
DonaldJE, ZhuH, LitvinovRI, DeGradoWF, BennettJS. Identification of interacting hot spots in the beta3 integrin stalk using comprehensive interface design. J Biol Chem, 2010; 285:38658–38665.
34.
YuW, YesupriyaA, WulfA, QuJ, KhouryMJ, GwinnM. An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics, 2007; 8:436.
35.
WeissLA, LesterLA, GernJEet al.Variation in ITGB3 is associated with asthma and sensitization to mold allergen in four populations. Am J Respir Crit Care Med, 2005; 172:67–73.
36.
ThompsonEE, PanL, OstrovnayaIet al.Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. J Allergy Clin Immunol, 2007; 119:1423–1429.
37.
RogersAJ, RabyBA, Lasky-SuJAet al.Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Am J Respir Crit Care Med, 2009; 179:1084–1090.
38.
GanterK, DeichmannKA, HeinzmannA. Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma. Int J Immunogenet, 2005; 32:233–236.
39.
PintoLA, DepnerM, KloppNet al.MMP-9 gene variants increase the risk for non-atopic asthma in children. Respir Res, 2010; 11:23.
40.
WinchesterEC, MillwoodIY, RandL, PennyMA, KesslingAM. Association of the TNF-alpha-308 (G—>A) polymorphism with self-reported history of childhood asthma. Hum Genet, 2000; 107:591–596.
41.
WitteJS, PalmerLJ, O'ConnorRD, HopkinsPJ, HallJM. Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma. Eur J Hum Genet, 2002; 10:82–85.
42.
ChamaryJV, ParmleyJL, HurstLD. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet, 2006; 7:98–108.
43.
KanayaS, YamadaY, KinouchiM, KudoY, IkemuraT. Codon usage and tRNA genes in eukaryotes: correlation of codon usage diversity with translation efficiency and with CG-dinucleotide usage as assessed by multivariate analysis. J Mol Evol, 2001; 53:290–298.
44.
ChamaryJV, HurstLD. Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol, 2005; 6:R75.
45.
CartegniL, ChewSL, KrainerAR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet, 2002; 3:285–298.
46.
TorgersonDG, AmplefordEJ, ChiuGYet al.Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet, 2011; 43:887–892.
47.
GalanterJM, TorgersonD, GignouxCRet al.Cosmopolitan and ethnic-specific replication of genetic risk factors for asthma in 2 Latino populations. J Allergy Clin Immunol, 2011; 128:37–43, e12.
48.
CorvolH, BurchardEG. Pharmacogenetic response to albuterol among asthmatics. Pharmacogenomics, 2008; 9:505–510.
49.
WoodruffPG, KothLL, YangYHet al.A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med, 2005; 172:1383–1392.
50.
ArjomandiM, DondeA, YellamelliA, BalmesJR. Osteopontin level in induced sputum is associated with FEV1 in asthmatic subjects. Am J Respir Crit Care Med, 2009; 175:A2862.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
